Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose Ulinastatin in Aortic Valve Surgery
NCT03154814Phase 4Completed
- Sponsor
- Konkuk University Medical Center
- Start
- Jan 2016
- Primary completion
- Apr 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of ulinastatin in postoperative pulmonary dysfunction (PPD) (2 arms), sponsored by Konkuk University Medical Center. Primary endpoint: Change of arterial oxygen partial pressure (PaO2)/fraction of inspired oxygen (FiO2). Started Jan 2016; status: completed.
02
Drugs
ulinastatin
03
Conditions
postoperative pulmonary dysfunction (PPD)
Beyond the preview
Go deeper on NCT03154814.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03154814.